6 times/cycle). If the patients want to continue the vaccination after completion of the first cycle of 6 vaccinations, the peptide vaccination will be allowed to continue (every 2-4 weeks).
Sponsors
Kurume University Cancer Vaccine Center
Conditions
colorectal cancergastric cancer
Phase 2
Phase II randomised clinical trial of personalized peptide vaccination in combination with Dai-kenchu-to for colorectal cancer patients resistant to standard therapies.
Active, not recruitingJPRN-UMIN000008126
Start: 2012-06-04Target: 60Updated: 2026-06-29
Phase II randomised clinical trial of personalized peptide vaccination in combination with Juzen-taiho-to for gastric cancer patients resistant to standard therapies .
Active, not recruitingJPRN-UMIN000008827
Start: 2012-09-01Target: 60Updated: 2026-06-29